1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adult Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Adult Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Influenza
1.4.3 Cervical Cancer
1.4.4 Zoster Shingles
1.4.5 Pneumococcal
1.4.6 Meningococcal
1.4.7 MMRV
1.4.8 Hepatitis
1.4.9 DTP
1.4.10 Travel and Miscellaneous
1.5 Market by Application
1.5.1 Global Adult Vaccine Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Medical Care Centers
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Adult Vaccine Market
1.8.1 Global Adult Vaccine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Adult Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Adult Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Adult Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Adult Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Adult Vaccine Sales Volume Market Share by Region (2015-2020)
3.2 Global Adult Vaccine Sales Revenue Market Share by Region (2015-2020)
3.3 North America Adult Vaccine Sales Volume
3.3.1 North America Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.3.2 North America Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Adult Vaccine Sales Volume
3.4.1 East Asia Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Adult Vaccine Sales Volume (2015-2020)
3.5.1 Europe Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Adult Vaccine Sales Volume (2015-2020)
3.6.1 South Asia Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Adult Vaccine Sales Volume (2015-2020)
3.7.1 Southeast Asia Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Adult Vaccine Sales Volume (2015-2020)
3.8.1 Middle East Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Adult Vaccine Sales Volume (2015-2020)
3.9.1 Africa Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Adult Vaccine Sales Volume (2015-2020)
3.10.1 Oceania Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Adult Vaccine Sales Volume (2015-2020)
3.11.1 South America Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.11.2 South America Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Adult Vaccine Sales Volume (2015-2020)
3.12.1 Rest of the World Adult Vaccine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Adult Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Adult Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Adult Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Adult Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Adult Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Adult Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Adult Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Adult Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Adult Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Adult Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Adult Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Adult Vaccine Sales Volume Market Share by Type (2015-2020)
14.2 Global Adult Vaccine Sales Revenue Market Share by Type (2015-2020)
14.3 Global Adult Vaccine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Adult Vaccine Consumption Volume by Application (2015-2020)
15.2 Global Adult Vaccine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Adult Vaccine Business
16.1 GlaxoSmithKline
16.1.1 GlaxoSmithKline Company Profile
16.1.2 GlaxoSmithKline Adult Vaccine Product Specification
16.1.3 GlaxoSmithKline Adult Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Novartis
16.2.1 Novartis Company Profile
16.2.2 Novartis Adult Vaccine Product Specification
16.2.3 Novartis Adult Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Sanofi Pasteur
16.3.1 Sanofi Pasteur Company Profile
16.3.2 Sanofi Pasteur Adult Vaccine Product Specification
16.3.3 Sanofi Pasteur Adult Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Protein Sciences
16.4.1 Protein Sciences Company Profile
16.4.2 Protein Sciences Adult Vaccine Product Specification
16.4.3 Protein Sciences Adult Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Merck
16.5.1 Merck Company Profile
16.5.2 Merck Adult Vaccine Product Specification
16.5.3 Merck Adult Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 BioCSL (Seqirus)
16.6.1 BioCSL (Seqirus) Company Profile
16.6.2 BioCSL (Seqirus) Adult Vaccine Product Specification
16.6.3 BioCSL (Seqirus) Adult Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Pfizer
16.7.1 Pfizer Company Profile
16.7.2 Pfizer Adult Vaccine Product Specification
16.7.3 Pfizer Adult Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Adult Vaccine Manufacturing Cost Analysis
17.1 Adult Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Adult Vaccine
17.4 Adult Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Adult Vaccine Distributors List
18.3 Adult Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Adult Vaccine (2021-2026)
20.2 Global Forecasted Revenue of Adult Vaccine (2021-2026)
20.3 Global Forecasted Price of Adult Vaccine (2015-2026)
20.4 Global Forecasted Production of Adult Vaccine by Region (2021-2026)
20.4.1 North America Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.3 Europe Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.7 Africa Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.9 South America Adult Vaccine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Adult Vaccine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Adult Vaccine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Adult Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Adult Vaccine by Country
21.3 Europe Market Forecasted Consumption of Adult Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Adult Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Adult Vaccine by Country
21.6 Middle East Forecasted Consumption of Adult Vaccine by Country
21.7 Africa Forecasted Consumption of Adult Vaccine by Country
21.8 Oceania Forecasted Consumption of Adult Vaccine by Country
21.9 South America Forecasted Consumption of Adult Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Adult Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer